BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18668429)

  • 1. Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis.
    Stahl S; Davies MR; Cook DI; Graham MJ
    Xenobiotica; 2008 Jul; 38(7-8):725-77. PubMed ID: 18668429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
    Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
    Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.
    Trauner M; Wagner M; Fickert P; Zollner G
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S111-24. PubMed ID: 15758646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
    Zollner G; Marschall HU; Wagner M; Trauner M
    Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear receptors as therapeutic targets in cholestatic liver diseases.
    Zollner G; Trauner M
    Br J Pharmacol; 2009 Jan; 156(1):7-27. PubMed ID: 19133988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis.
    Wagner M; Trauner M
    Ann Hepatol; 2005; 4(2):77-99. PubMed ID: 16010241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid transporters: structure, function, regulation and pathophysiological implications.
    Alrefai WA; Gill RK
    Pharm Res; 2007 Oct; 24(10):1803-23. PubMed ID: 17404808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of farnesoid X receptor in cholestasis.
    Yuan ZQ; Li KW
    J Dig Dis; 2016 Aug; 17(8):501-509. PubMed ID: 27383832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
    Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of cholestasis.
    Zollner G; Trauner M
    Wien Med Wochenschr; 2006 Jul; 156(13-14):380-5. PubMed ID: 16937039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile salt transporters: molecular characterization, function, and regulation.
    Trauner M; Boyer JL
    Physiol Rev; 2003 Apr; 83(2):633-71. PubMed ID: 12663868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.
    Zollner G; Fickert P; Silbert D; Fuchsbichler A; Marschall HU; Zatloukal K; Denk H; Trauner M
    J Hepatol; 2003 Jun; 38(6):717-27. PubMed ID: 12763363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats.
    Wang L; Wu G; Wu F; Jiang N; Lin Y
    J Ethnopharmacol; 2017 Jan; 196():178-185. PubMed ID: 27988401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders.
    Molinaro A; Marschall HU
    Biochem Soc Trans; 2022 Feb; 50(1):361-373. PubMed ID: 35191955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXR and PXR: potential therapeutic targets in cholestasis.
    Jonker JW; Liddle C; Downes M
    J Steroid Biochem Mol Biol; 2012 Jul; 130(3-5):147-58. PubMed ID: 21801835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of canalicular ABC transporters in cholestasis.
    Cuperus FJ; Claudel T; Gautherot J; Halilbasic E; Trauner M
    Drug Metab Dispos; 2014 Apr; 42(4):546-60. PubMed ID: 24474736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis.
    Wagner M; Zollner G; Trauner M
    Semin Liver Dis; 2010 May; 30(2):160-77. PubMed ID: 20422498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular bile salt transport: lessons from cholestasis.
    Trauner M; Fickert P; Stauber RE
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():99D-104D. PubMed ID: 11110621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.